Legislation
Schools have a legal duty to make arrangements for pupils with medical conditions (including those with food allergies) under the Children and Families Act 2014. For allergies, this requirement is supported by the statutory guidance Allergy safety in schools.
All pupils with medical conditions (including allergies) which have a functional impact on them in their school or educational setting should have an Individual Healthcare Plan agreed between the parents and the school. This is particularly important where self-administered adrenaline devices (ADs) have been prescribed for use in emergencies.
Teachers and other non-healthcare professionals are permitted – but not obligated – to administer ADs under existing legislation, but only to the person the device has been prescribed. They cannot use an AD prescribed to child ‘A’ to treat anaphylaxis occurring in child ‘B’.
In 2017, the law was changed: the Human Medicines (Amendment) Regulations 2017 now allows schools to obtain, without a prescription, “spare” adrenaline autoinjector (AAI) devices for use in emergencies. Only those institutions described in regulation 22 of the Human Medicines (No.2) Regulations 2014 may legally hold “spare” AAIs – this includes all primary and secondary schools (including independent schools) in the UK.
“Spare” AAIs are in addition to any ADs a pupil might be prescribed and bring to school. The “spare” AAI(s) can be used if the pupil’s own prescribed devices are not immediately available (for example, because they are broken, out-of-date, have misfired or been wrongly administered).
From September 2026, schools must have an allergy safety policy and must “have regard” to the Allergy safety in schools statutory guidance. Under this guidance, there is an expectation that schools should hold “spare” AAIs, and arrange allergy awareness training for all staff. Under the Children’s Wellbeing and Schools Act 2026, the Government will be bringing in Regulations in 2027 which will make allergy awareness training a legal requirement for schools, and mandate schools to hold spare adrenaline devices for use in an emergency.
“Spare” AAI devices can be used in any pupil known to be at risk of anaphylaxis, so long as the school have medical approval for the “spare” AAI to be used in a specific pupil, and the child’s parent/guardian has provided written authorisation.
Not all children with food allergies and at risk of anaphylaxis are prescribed adrenaline devices. These children can still be given a spare AAI in an anaphylaxis emergency.
All children with food allergies which require the school to take risk-reduction measures and who might need the spare adrenaline device should have an Individualised Healthcare Plan (IHP). Click on the link for further information.
Under the Human Medicines (Amendment) Regulations 2017, in an emergency which could not be foreseen, written consent is not required for “spare” adrenaline devices to be used. This includes the “spare” device being used in anyone (including adult visitors) having anaphylaxis on school premises.
It is good practice for the school, college or setting to obtain advance consent from parents or the young person for “spare” adrenaline devices to be used, so that in an emergency, consent can be assumed to be in place. However, in an emergency situation anyone may take reasonable action to save a life without checking whether prior consent has been given, in order to avoid delays in treatment.
Therefore, if someone on school premises may be having anaphylaxis:
- If the child, young person or individual has their own prescribed adrenaline devices, these should be used in the first instance.
- If the child, young person or individual does not have prescribed adrenaline devices, “spare” adrenaline devices can be used.
- If the child, young person or individual’s prescribed adrenaline devices are not available or misfire, “spare” adrenaline devices can be used.
To support schools, the Department of Health and Social Care together with key stakeholders has developed guidance, to be read in conjunction with the Allergy safety in schools statutory guidance. Schools should use both of these documents as the basis for any protocol or policy relating to food allergies and the use of adrenaline devices to treat allergic reactions.
Liability and indemnity
Schools should have appropriate levels of insurance in place to cover staff when supporting pupils with medical conditions; this includes liability cover relating to the administration of medication such as adrenaline devices. This is a legal requirement under Supporting Pupils. The only exception to this are acts of serious and wilful misconduct. Carelessness or a simple mistake does not amount to serious and wilful misconduct.
Local Authorities may provide schools with appropriate indemnity cover; however schools need to agree any such cover directly with the relevant authority. Academies should ensure that either the appropriate level of insurance is in place, or that the academy is a member of the Department for Education’s Risk Protection Arrangement (RPA).
